great contribution, congrats James!

Check out the recent paper on handling uncertainty in cost-effectiveness analysis under risk-aversion published in PharmacoEconomics. #HEOR #healthcare #HTA. link.springer.com/article/10.100…

Happy to share with you the paper that introduces the cost-effectiveness risk-aversion curve. As the COVID crisis has shown us, decision-makers are highly risk-averse towards health outcomes and, ceteris paribus, also towards costs. link.springer.com/article/10.100…

cost-effectiveness analysis under risk-aversion, some thoghts how we could address these issues link.springer.com/article/10.100…

Great The Centre for Health Economics economic evaluation seminar this week by Pedram Sendi - many thanks. Hoping to try out some of the indices discussed in future work around local decision-making with @Franklin86Matt, danielhowdon, Seb Hinde et al 🤞

Prevalence of Missing Values and Protest Zeros in Contingent Valuation in Dental Medicine mdpi.com/1178410 ##mdpiijerph via IJERPH

Just out, happy to share with you our recent paper on handling uncertainty in cost-effectiveness analysis with a focus on budget constraints and risk-version, together with Klazien Matter-Walstra and Matthias Schwenkglenks. mdpi.com/2227-9032/9/11…